AI, machine learning, and NLP are revolutionizing healthcare through data analysis. Premier Inc. exemplifies this transformation, showcasing how AI optimizes patient selection for trials, identifies diseases like lung cancer, and enhances dementia care. By…
Continue Reading
Fertility care provider Ovum Health has partnered with IBM to scale its web and mobile app-based chat and scheduling solution with AI.Alice Crisci, a healthcare activist, mum to a fertility preservation miracle, business owner…
Continue Reading
mTuitive, a leading provider of data enablement solutions for healthcare, announced its groundbreaking new mTuitive Insight engine to give power to structured cancer data and provide a comprehensive view of this data for healthcare…
Continue Reading
This session covered topics important to the future of clinical decision support. The session began with education sessions on CDS Hooks, SMART apps, and CDS Connect. Then, speakers discussed patient-centered CDS, focusing on the…
Continue Reading
Pharmacogenomics has the potential to save money for the health service and contribute to advances in personalised medicine, speakers told a panel at this week’s HETT conference in London, but stakeholders will need to…
Continue Reading
Mevion Medical Systems is set to transform proton therapy at ASTRO 2023 with groundbreaking innovations. They’ve achieved the world’s first proton therapy system designed to fit into traditional LINAC vaults, enhancing accessibility. Collaborating with…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
Blue Earth Diagnostics, a leading provider of PET radiopharmaceuticals, is set to present findings on POSLUMA (flotufolastat F 18) injection at the ASTRO 2023 Annual Meeting. POSLUMA aids in PET scans to detect prostate-specific…
Continue Reading
Blood cancers are classified into three main types, each with several subtypes. The underlying cause is attributed to mutations in the DNA of blood cells that disrupt the normal control mechanisms that regulate cell…
Continue Reading
By Shania Kennedy
September 27, 2023 – Researchers at the University of Texas at Arlington (UTA) have been awarded a $450,000 grant from the National Institute of General Medical Sciences to develop a machine learning-based model…
Continue Reading
